Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT ID: NCT01604395
Last Updated: 2021-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6000 participants
OBSERVATIONAL
2012-01-31
2032-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690
Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients
NCT02042170
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
NCT03535415
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
NCT01066052
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
NCT03015909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
growth hormone
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children with GHD,TS, CRF, SGA or ISS
* written informed consent from the person, person's parent or legal guardian
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LG Chem
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HW Chae, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kangnam severance hospital
KS Sim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kangdong KyungHee University hospital
IT Hwang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kangdong Sacred Heart Hospital
SC Chung, M.D.
Role: PRINCIPAL_INVESTIGATOR
Konkook University hospital
CW Ko, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kyungpook National University Hospital
HS Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Keimyung University hospital
YJ Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Korea University
KH Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Korea University Anam Hospital
JH Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Kosin university hospital
JS Yu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Dankook University
JH Yu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Dong-A University Hospital
SY Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
SMG-SNU Boramae Medical Center
WY Chung, M.D.
Role: PRINCIPAL_INVESTIGATOR
Inje University
Yl Shin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Buchun Soonchunhyang university hospital
CY Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
daejin medical center
DK Jin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
MJ Park, M.D.
Role: PRINCIPAL_INVESTIGATOR
Inje University
CH Shin, M.D.
Role: STUDY_CHAIR
Seoul National University Hospital
BK Suh, M.D.
Role: PRINCIPAL_INVESTIGATOR
Seoul St. Mary's Hospital
HW Yoo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
MH Jung, M.D.
Role: PRINCIPAL_INVESTIGATOR
Yeouide St. Mary's hospital
SH Park, M.D.
Role: PRINCIPAL_INVESTIGATOR
St Vincent's Hospital
DH Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sowha children's hospital
DH Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Seoul Soonchunhyang university hospital
HS Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sinchon severance hospital
JS Hwang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ajou University School of Medicine
SY Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Pusan National University Yangsan Hospital
JD Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Wonkwang university school of medicine & hospital
HS Han, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chungbuk National University Hospital
KH Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Wonkwang University Sanbon Medical Center
EK Yoo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Bunsangcha hospital
BK Lim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Wonju Christian Hospital
JH Kang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Eulji University Hospital
JY Seo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Eulji General Hospital
HS Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
ehwa university medical center
JE Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Inha University Hospital
JH Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Inje University
CJ Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chonnam National University Hospital
DY Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chonbuk National University Hospital
KS Shin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Jeju National University Hospital
IT Hwang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hallym University Medical Center
SM Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hanyang University
KH Lee, M.D.
Role: PRINCIPAL_INVESTIGATOR
Korea University Guro Hospital
KS Jo, M.D.
Role: PRINCIPAL_INVESTIGATOR
Bucheon St. Mary's Hospital
SY Ahn, M.D.
Role: PRINCIPAL_INVESTIGATOR
KangWon National University Hospital
PS Oh, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chuncheon Sacred Heart Hospital
S Yang, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hallym University Kangnam Sacred Heart Hospital
EY Kim, M.D.
Role: PRINCIPAL_INVESTIGATOR
Chosun University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
CH Shin, M.D.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kim JH, Kim SJ, Chung IH, Lim JS. Adiposity Rebound Timing in Small for Gestational Age Children Treated With Growth Hormone: Results From LG Growth Study Data. J Korean Med Sci. 2025 Feb 3;40(4):e12. doi: 10.3346/jkms.2025.40.e12.
Jeong HR, Lee HS, Hwang JS. Growth Prediction Model for Prepubertal Children With Idiopathic Growth Hormone Deficiency: An Analysis of LG Growth Study Data. Clin Endocrinol (Oxf). 2025 Mar;102(3):281-287. doi: 10.1111/cen.15178. Epub 2024 Dec 15.
Lee HS, Kum CD, Rho JG, Hwang JS. Long-term effectiveness of growth hormone therapy in children born small for gestational age: An analysis of LG growth study data. PLoS One. 2022 Apr 26;17(4):e0266329. doi: 10.1371/journal.pone.0266329. eCollection 2022.
Lim HH, Kim YM, Lee GM, Yu J, Han HS, Yu J. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency. J Korean Med Sci. 2022 Mar 21;37(11):e90. doi: 10.3346/jkms.2022.37.e90.
Cho WK, Ahn MB, Kim EY, Cho KS, Jung MH, Suh BK. Predicting First-Year Growth in Response to Growth Hormone Treatment in Prepubertal Korean Children with Idiopathic Growth Hormone Deficiency: Analysis of Data from the LG Growth Study Database. J Korean Med Sci. 2020 May 18;35(19):e151. doi: 10.3346/jkms.2020.35.e151.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LG-HGOS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.